Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts

Cancer Research

Volumn 64, Issue 23, 2004, Pages 8492-8495

  Direkze, Natalie C ^a,b,e   Hodivala Dilke, Kairbaan ^a,c   Jeffery, Rosemary ^a   Hunt, Toby ^a   Poulsom, Richard ^a   Oukrif, Dahmane ^d   Alison, Malcolm R ^a,c   Wright, Nicholas A ^a,c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Histopathology Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; CD45 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEIN; INSULIN; UNCLASSIFIED DRUG; VIMENTIN; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL TYPE; CONTROLLED STUDY; FEMALE; FIBROBLAST; FIBROSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULINOMA; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; STROMA; TISSUE REPAIR; TRANSGENIC MOUSE;

ACTINS; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; FEMALE; FIBROBLASTS; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULINOMA; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH; PANCREATIC NEOPLASMS;

EID: 9244236047     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1708     Document Type: Article

References (19)

1. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts: I. Paracrine cells important in health and disease. Am J Physiol 1999;277:C1-9.
2. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003;200:429-47.
3. Direkze NC, Forbes SJ, Brittan M, et al. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 2003;21:514-20.
4. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985;315:115-22.
5. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature (Lond) 2001;411:375-9.
6. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166:7556-62.
7. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003;200:500-3.
8. Lieubeau B, Heymann MF, Henry F, Barbieux I, Meflah K, Gregoire M. Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int J Cancer 1999;81:629-36.
9. Ng IO, Lai EC, Ng MM, Fan ST. Tumor encapsulation in hepatocellular carcinoma: a pathologic study of 189 cases. Cancer (Phila) 1992;70:45-9.
10. Opdenakker G, Van Damme J. Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol Today 1992;13:463-4.
11. Ooi LP, Crawford DH, Gotley DC, et al. Evidence that "myofibroblast- like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol 1997;26:798-807.
12. Bridle KR, Crawford DH, Powell LW, Ramm GA. Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis. Liver 2001;21:96-104.
13. Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut 2004;53:581-6.
14. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Investig 2003;112:1776-84.
15. Nakayama H, Enzan H, Miyazaki E, Kuroda N, Naruse K, Hiroi M. Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma. J Clin Pathol 2000;53:626-9.
16. Chauhan H, Abraham A, Phillips JR, Pringle JH, Walker RA, Jones JL. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J Clin Pathol 2003;56:271-6.
17. Kuroda N, Toi M, Nakayama H, et al. The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions. Histol Histopathol 2004;19:59-67.
18. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Investig 2003;111:843-50.
19. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature (Lond) 2003;422:897-901.